对阿尔茨海默氏病中Aβ聚合物的多巴胺介导的形式转换的计算洞察力
Sunandini Swain1, Atanu K Metya1
1Department of Chemical and Biochemical Engineering, Indian Institute of Technology Patna, Patna-801106, India.
ACS chemical neuroscience
|September 17, 2025
概括
多巴胺破坏了早期阿尔茨海默病 (AD) 的粉样β (Aβ) 聚合,特别是在单体和三元体阶段. 它的有效性随着Aβ组件的扩大而下降,这表明早期AD治疗的潜力.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 计算生物学 计算生物学
背景情况:
- 阿尔茨海默病 (AD) 是一种具有复杂原因的渐进性神经退行性疾病,影响全球数百万人.
- 多巴胺功能障碍与AD症状,如认知衰退和抑郁症有关.
- 在AD病变发生过程中,多巴胺与粉样β (Aβ) 相互作用的确切分子机制尚未完全理解.
研究的目的:
- 用分子动力学 (MD) 模拟来研究多巴胺在各种聚合状态下与Aβ的结构特异性相互作用.
- 阐明多巴胺如何影响Aβ在聚合的早期阶段的结构动态.
主要方法:
- 利用分子动力学 (MD) 模拟来模拟多巴胺与Aβ单体,三元体,五元体和纤维状组件的相互作用.
- 分析了对多巴胺结合的反应中的形状变化,β-片的破坏和α-螺旋体的形成.
主要成果:
- 多巴胺显著扰乱Aβ单体和三元体,破坏β片结构并促进α螺旋体的形成.
- 在Aβ五聚体中观察到中间不稳定,带有部分α螺旋诱导和弱化的链际相互作用.
- 成熟的Aβ纤维呈现结构刚性,形状变化最小,β片含量没有被破坏.
结论:
- 多巴胺选择性地干扰了Aβ聚合的早期核化阶段,而不是纤维细胞延长.
- 多巴胺对Aβ结构的破坏性影响依赖于形状,随着聚合状态的增加而减少.
- 这些发现提供了对多巴胺在调节早期粉胺基因事件中的作用的见解,并建议对AD的潜在治疗策略.
相关概念视频
Amyloid Fibrils
11.7K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.7K
Amyloid Fibrils
6.3K
6.3K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


